Evidence by drug
Metronomic capecitabine
188 studies and 95 trials indexed. 24 trials are recruiting or about to start.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
Trials recruiting or starting soon
- RecruitingPhase 2ChinaNCT06787339Capecitabine in Low Risk Triple Negative Breast CancerFudan University
- RecruitingPhase 2CanadaNCT07631052Capecitabine in ER+/HER2-negative Breast CancerUniversity Health Network, Toronto
- RecruitingPhase 2SingaporeNCT05929885Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer PatientsNational Cancer Centre, Singapore
- RecruitingPhase 2ChinaNCT06771609Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- RecruitingPhase 3ChinaNCT07590024RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal CarcinomaCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RecruitingNot statedChinaNCT07618078Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPCCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RecruitingPhase 3ChinaNCT07177794Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCCSun Yat-sen University
- RecruitingPhase 2SingaporeNCT06093061Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal CarcinomaNational Cancer Centre, Singapore
- RecruitingPhase 3ChinaNCT07467330Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line TreatmentFujian Cancer Hospital
- RecruitingPhase 3ChinaNCT06239727Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment ResponseSun Yat-sen University
- RecruitingPhase 2United StatesNCT06085742BRE-08 Phase II Study of CMC Regimen for Early Stage Breast CancerUniversity of Illinois Chicago
- RecruitingPhase 3ChinaNCT07154069Adaptive Immunotherapy for Nasopharyngeal CarcinomaSun Yat-sen University
- RecruitingPhase 2ChinaNCT06494995AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic TherapyFudan University
- RecruitingPhase 2ItalyNCT06800391Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei PatientsFondazione IRCCS Istituto Nazionale dei Tumori, Milano
- RecruitingNot statedChinaNCT06700382Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBCShu Wang
- RecruitingPhase 3ChinaNCT05063136Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast CancerHenan Cancer Hospital
- RecruitingPhase 3ChinaNCT06313567Metronomic Capecitabine in Stage III Gastric CancerFudan University
- RecruitingNot statedChinaNCT05940441A Prospective Exploratory Clinical Study of Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Hypopharyngeal CarcinomaEye & ENT Hospital of Fudan University
- RecruitingPhase 3ChinaNCT05342792Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal CarcinomaSun Yat-sen University
- RecruitingPhase 3ChinaNCT03561740A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTientsSun Yat-sen University
- Not yet recruitingPhase 2NCT07019337Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences
- Not yet recruitingPhase 2ChinaNCT06759090Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic CancerZhejiang University
- Not yet recruitingPhase 2NCT06229067Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences
- Not yet recruitingPhase 3ChinaNCT05172518Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast CancerSun Yat-sen University
Newest studies
- StudyJ Clin Oncol2026 Nov 10Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline Update.Chen YP, et al.
- StudyDrug Deliv Transl Res2026 NovChemotherapeutic efficacy of nano formulation capecitabine@SNPs and gamma radiation: a novel metronomic approach for breast cancer treatment.Ghanim MI, et al.
- ReviewCancers (Basel)2026 Aug 3Predictive Biomarkers of Metronomic Chemotherapy Response in Solid Tumors: Chasing an Elusive Signal.Wysocki PJ, et al.
- StudyJCO Precis Oncol2026 AugDPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective Study.Schettini F, et al.
- StudyCancers (Basel)2026 Jul 17Adverse Events as a Surrogate of Sufficient Pharmacological Exposure in Metronomic Combination Chemotherapy: Extended Real-World Cohort Analysis of the FulVEC Regimen in Metastatic ER+/HER2- Breast Cancer.Buda-Nowak A, et al.
- StudyDis Esophagus2026 Jul 2Lessons learned from the use of capecitabine-based triplet neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.Shah M, et al.
- Phase 3 trialNat Cancer2026 JulLong-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.Tao YL, et al.
- ReviewCurr Opin Oncol2026 Jul 1From dose to exposure? rethinking fluoropyrimidines as immune checkpoint partners in gastrointestinal cancers.Hendlisz A, et al.
- Case reportFront Immunol2026Case Report: Long-term disease control with immunotherapy in primary mandibular adenoid cystic carcinoma presenting with pulmonary metastasis.Yang H, et al.
- StudyCancer Med2026 JunReal-World Efficacy of Metronomic Chemotherapy in Advanced Breast Cancer Across Molecular Subtypes.Zhou H, et al.
- StudyCancer Med2026 MayMetronomic Capecitabine Triggers Ferroptosis in Hepatocellular Carcinoma Cells Through Inhibition of TYMS.Yang R, et al.
- Clinical trialSignal Transduct Target Ther2026 Apr 15HDAC inhibitor tucidinostat and metronomic capecitabine plus endocrine therapy for patients with HR-positive HER2-negative advanced breast cancer after CDK4/6 inhibitors treatment: clinical findings and exploratory circulating tumor cell and ctDNA biomarker analyses of a multicenter, phase 2 study (SYSUCC-020 trial).Wu HL, et al.
- StudyIndian J Surg Oncol2026 AprEfficacy of Metronomic Oral Capecitabine, Methotrexate and Cyclophosphamide in Locally Advanced Operable Oral Cavity Squamous Cell Carcinoma - A Phase II Study.Chanda S, et al.
- StudyCureus2026 MarLow-Dose Metronomic Chemotherapy With Fixed Low-Dose Nivolumab for Recurrent Cervical Cancer After Radiotherapy: Experience From Routine Clinical Practice.Ramidi GR, et al.
- StudyNaunyn Schmiedebergs Arch Pharmacol2026 MarEfficacy of fulvestrant and capecitabine as maintenance therapy in patients with HR +/HER2 - metastatic breast cancer benefited from first-line chemotherapy.Liu Q, et al.
- ReviewFront Pharmacol2026Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias.Harrer DC, et al.
- StudyESMO Real World Data Digit Oncol2026 MarSecond-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.Cazzaniga ME, et al.
- Clinical trialInt J Cancer2026 Jan 1Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo-refractory gastrointestinal cancers.Spehner L, et al.
- StudyAm J Transl Res2025Early capecitabine metronomic chemotherapy improves patient prognosis and safety in early-stage triple-negative breast cancer.Sun Y, et al.
- StudyESMO Gastrointest Oncol2025 DecRegorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trial.El Kaddissi A, et al.
- StudyChin Clin Oncol2025 DecMetronomic capecitabine plus aromatase inhibitor as initial therapy in HR-positive HER2-negative metastatic breast cancer: a low-cost and easily implementable option.Narvaez D, et al.
- Phase 3 trialLancet Oncol2025 DecMetronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial.Yuan J, et al.
- Meta-analysisHead Neck2025 NovEfficacy and Safety of Adjuvant Capecitabine in Locoregionally Advanced Nasopharyngeal Carcinoma: A Meta-Analysis of Phase III Randomized Trials With Subgroup Analysis by Neoadjuvant Chemotherapy.Ben Kridis W and Khanfir A
- Clinical trialBMC Med2025 Oct 21Lipid metabolism associated with efficacy of metronomic capecitabine and camrelizumab in gastrointestinal cancer: an exploratory clinical trial.Zhou C, et al.
- Phase 3 trialCancer Lett2025 Jul 1Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory/ineligible head and neck cancer in palliative setting with survival outcomes.Kothari R, et al.
- StudyMedComm (2020)2025 JulTriplet Regimen of Metronomic Capecitabine Plus Antiangiogenic Drug and PD-1 Inhibitor as Later-Line Salvage Treatment for Patients With MSS/pMMR Metastatic Colorectal Cancer: A Retrospective Study.Yang Q, et al.
- StudyClin Breast Cancer2025 JunOptimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials.Trapani D, et al.
- Clinical trialPLoS One2025Capecitabine metronomic chemotherapy for metastatic colorectal cancer patients reaching NED: A protocol for a prospective, randomized, controlled trial.Wu J, et al.
- Phase 3 trialJ Clin Oncol2025 Apr 10Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: The Phase III MECCA Trial.Hong RX, et al.
- StudyBreast2025 AprCorrigendum to "Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial" [The Breast 78 (2004) 103795].Larsson F K, et al.
- Clinical trialCancer Res Treat2025 AprCombination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study.Hao C, et al.
- Randomized trialJ Chemother2025 AprCombination of metronomic capecitabine and letrozole in metastatic hormone receptor positive, HER2 negative breast cancer: a randomized phase II trial.Azim HA, et al.
- StudyOncotarget2025 Feb 12Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen.Gamal DA, et al.
- StudyThorac Cancer2025 FebEfficacy and Safety of Low-Dose Oral Etoposide Combined With Capecitabine for Patients With Postoperative Metastatic Breast Cancer Resistant to Anthracycline/Taxanes.Chen X, et al.
- StudyBMC Cancer2025 Jan 3Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: an observational and retrospective study.Liu J, et al.
- Clinical trialSignal Transduct Target Ther2024 Dec 9Anlotinib plus chemotherapy as a first-line treatment for gastrointestinal cancer patients with unresectable liver metastases: a multicohort, multicenter, exploratory trial.Wu JW, et al.
- Clinical trialBreast2024 DecMetronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial.Larsson K F, et al.
- Meta-analysisJ Gastrointest Cancer2024 DecEfficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.Gupta N, et al.
- StudyOral Oncol2024 NovGemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study.Yang R, et al.
- StudyBiomaterials2024 OctImmune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathway.Park SJ, et al.
